Invenomic Capital Management LP
•CIK: 1769456•Filing: Q4 2025
**Invenomic Capital Management LP** manages $2.1B across a diversified portfolio of 147 positions. The fund exhibits concentrated exposure, with top holdings including VTRS at $69.6M and GPN at $61.7M. Notable allocations also feature XRAY ($58.7M), AKAM ($58.6M), and AZO ($54.3M). This structure suggests a focused, high-conviction approach across select market sectors.
Total AUM
$2.1B
+ $77.3M in options
QoQ Performance
+8.3%
Positions
144
+ 3 options
Top 10 Concentration
24.9%
Latest Filing
Q4 2025
Top Holdings Allocation
VTRS3.2%
GPN2.9%
XRAY2.7%
AKAM2.7%
AZO2.5%
ELD2.5%
ACHC2.2%
RNG2.1%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other98.2%
Energy0.7%
Technology0.6%
Financial0.4%
Communication0.1%
🚪 Exited Positionssold since Q3 2025
+22 more exited positions
Changes from Q3 2025
NEW31 new positions
↑73 increased
↓40 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023